Skip to main content
. Author manuscript; available in PMC: 2024 Oct 17.
Published in final edited form as: AIDS Care. 2022 Apr 25;35(6):867–875. doi: 10.1080/09540121.2022.2067311

Table 2:

Prevalence of HIV screening by characteristics among heterosexually active persons – National HIV Behavioral Surveillance, 2016

Total N = 7,777 Ever Screened N = 6,273 Never Screened N = 1,504 Crude PR (95% CI) Adjusted PR (95% CI)

Row %
IPV (in Past 12 months)
 Yes 16.8 82.9 17.1 1.03 (1.01–1.06) 1.03 (1.00–1.06)
 No 83.3 80.2 19.8 1.0 1.0
Socio-demographic
Gender
 Male 45.3 77.8 22.3 0.94 (0.91–0.96) 0.92 (0.90–0.95)
 Female 54.8 83.1 16.9 1.0 1.0
Age (years)
 18–24 19.6 66.0 34.0 0.81 (0.76–0.85) 0.81 (0.77–0.86)
 25–29 13.9 82.0 18.0 1.0 1.0
 30–39 20.7 88.5 11.6 1.08 (1.04–1.12) 1.08 (1.04–1.12)
 40–49 20.2 85.8 14.3 1.05 (1.01–1.09) 1.04 (1.01–1.08)
 50–60 25.6 80.8 19.2 0.99 (0.95–1.03) 0.98 (0.94–1.01)
Race/Ethnicity
 Black 71.4 83.9 16.1 1.15 (1.05–1.26) 1.08 (1.01–1.15)
 Hispanic 20.0 70.4 29.6 0.96 (0.87–1.07) 0.94 (0.87–1.03)
 White 3.6 73.0 27.0 1.0 1.0
 Other 4.9 82.0 18.0 1.12 (1.02–1.22) 1.09 (1.01–1.19)
Education
 <High School 29.2 79.9 20.1 0.94 (0.90–0.98) 0.92 (0.88–0.95)
 High School 53.6 79.6 20.4 0.93 (0.89–0.97) 0.91 (0.88–0.95)
 >High School 17.2 85.3 14.7 1.0 1.0
Household income
 Above the Federal Poverty Level 15.9 76.2 23.8 1.0 1.0
 At or Below the Federal Poverty Level 84.1 81.6 18.4 1.07 (1.02–1.12) 1.06 (1.02–1.10)
Insurance
 Private 6.8 73.0 27.1 1.0 1.0
 Medicaid 49.4 83.6 16.4 1.15 (1.04–1.26) 1.12 (1.03–1.22)
 Medicare 4.2 82.9 17.1 1.14 (1.03–1.25) 1.11 (1.02–1.20)
 Other 10.5 78.3 21.7 1.07 (0.96–1.20) 1.12 (1.03–1.22)
 Multiple 5.5 86.8 13.2 1.19 (1.08–1.32) 1.15 (1.06–1.26)
 None 23.7 76.3 23.7 1.05 (0.96–1.14) 1.02 (0.95–1.10)
HIV Screening Offered by Health Care Provider (in Past 12 months)
 Offered 36.6 96.3 3.7 1.0 1.0
 Not Offered 44.8 72.9 27.1 0.76 (0.72–0.79) 0.78 (0.74–0.81)
 No Visit 18.6 68.7 31.3 0.71 (0.67–0.76) 0.73 (0.69–0.77)
Risk Factors for HIV
Ever Injected Drugs
 Yes 5.1 85.6 14.4 1.06 (1.02–1.11) 1.07 (1.02–1.11)
 No 94.9 80.4 19.6 1.0 1.0
Last Sexual Partner Ever Injected Drugs
 Yes 10.5 79.8 20.2 0.99 (0.95–1.03) 1.00 (0.95–1.04)
 No 89.5 80.8 19.3 1.0 1.0
Exchanged Sex for Money or Drugs With Casual Partner(s) (in Past 12 months)
 Yes 17.7 82.9 17.1 1.03 (1.00–1.07) 1.00 (0.98–1.03)
 No 82.3 80.2 19.8 1.0 1.0
Condomless Sex With HIV Positive Partner (in Past 12 months)
 Yes 1.1 81.8 18.2 1.01 (0.87–1.17) 0.97 (0.83–1.14)
 No 98.9 81.0 19.1 1.0 1.0
Number of Sexual Partners (in Past 12 months)
 1 partner 36.4 81.5 18.5 1.0 1.0
 2 partners 20.0 81.3 18.7 1.00 (0.97–1.03) 1.00 (0.97–1.03)
 3 partners 13.6 81.4 18.6 1.00 (0.95–1.05) 0.99 (0.95–1.04)
 ≥4 partners 30.1 78.9 21.1 0.97 (0.93–1.00) 0.96 (0.93–0.99)
Last Sexual Partner Had Sex With Other People (in Past 12 months)
 Yes 45.8 81.9 18.1 1.03 (1.01–1.05) 1.02 (1.00–1.04)
 No 54.2 79.5 20.5 1.0 1.0
STD Diagnosis (in Past 12 months)
 Yes 6.9 84.1 15.9 1.05 (1.01–1.09) 1.04 (1.00–1.07)
 No 93.1 80.4 19.6 1.0 1.0
Any Risk Behavior
 Yes 66.3 81.6 18.4 1.03 (1.0–1.05) 1.01 (0.99–1.04)
 No 33.7 79.5 20.5 1.0 1.0

PR, prevalence ratio; STD, sexually transmitted disease.

Note: Race/ethnicity categories are mutually exclusive and Hispanics can be of any race; household income is based on the 2015 federal poverty level; any risk behavior (i.e., ever injected drugs, last sexual partner ever injected drugs, exchanged sex for money or drugs with casual partner(s) in past 12 months, condomless sex with HIV positive partner in past 12 months, four or more sexual partners in past 12 months, last sexual partner had sex with other people in past 12 months, STD diagnosis in past 12 months); log-linked Poisson Regression was generated using generalized estimating equations (GEE) clustered on recruitment chains from seeds in respondent-driven sampling. Adjusted model controls for city of interview and network size. Bolded statistically significant results.